Translate

Thứ Tư, 20 tháng 5, 2020

New hope in the fight against Covid-19

America’s biopharmaceutical companies are committed to developing solutions to help diagnose and treat those with COVID-19, a disease caused by a novel strain of coronavirus. In addition to applying their scientific expertise to find ways to diagnose, treat and prevent infections from the virus, the biopharmaceutical industry is providing financial support and in-kind donations to organizations and collaborating with U.S. and global health authorities to combat this global public health emergency. More than half of PhRMA members have R&D for potential treatments and vaccines unde way or are providing donations of medicines and critical medical supplies as well as providing financial donations to support patients and first responders in addressing this evolving crisis.

Không có nhận xét nào:

Đăng nhận xét